SCHEMBL9733728

SCHEMBL9733728

COC(=O)CC(C)C(=O)c1ccc(OC)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
HTT P42858 2/20 0.51
CA1 P00915 5/20 0.50
CA2 P00918 5/20 0.50
TDP1 Q9NUW8 2/20 0.49
SLC2A1 P11166 1/20 0.49
CYP1A2 P05177 1/20 0.49
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
LMNA P02545 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
MMP1 P03956 1/20 0.47
PLK1 P53350 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
GSK3B P49841 1/20 0.46
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6287509 0.86 CES2 (0.52) ALDH1A1HTTCA1CA2TDP1
SCHEMBL1373036 0.86 TDP1 (0.49) ALDH1A1CA1CA2TDP1CYP1A2
SCHEMBL9734549 0.85 CA1 (0.48) ALDH1A1CA1CA2TDP1CYP1A2
SCHEMBL8213432 0.85 ALDH1A1 (0.54) ALDH1A1HTTCA1CA2TDP1
SCHEMBL9780181 0.83 KCNA5 (0.38) ALDH1A1HTTTDP1CYP1A2MEN1
SCHEMBL8535929 0.83 KCNA5 (0.49) ALDH1A1TDP1MEN1KMT2ALMNA
SCHEMBL1108991 0.82 ALDH1A1 (0.55) ALDH1A1HTTCA1CA2TDP1
SCHEMBL10696373 0.81 CES2 (0.54) ALDH1A1CES2CES1MEN1KMT2A
SCHEMBL9733588 0.81 MAPT (0.45) HTTSLC2A1MEN1KMT2ALMNA
SCHEMBL2423154 0.81 CES2 (0.53) ALDH1A1HTTCA1CA2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5135940-A Antiallegens, antiinflammatory agents MERCK FROSST CANADA, INC. (CA) 1992-08-04 US disclosed
EP-0252639-A1 Leukotriene antagonists MERCK FROSST CANADA INC. (CA) 1988-01-13 EP disclosed
EP-0104885-B1 LEUKOTRIENE ANTAGONISTS, THEIR PRODUCTION, AND COMPOSITIONS CONTAINING THEM MERCK FROSST CANADA INC. (CA) 1986-06-04 EP disclosed
EP-0156233-A2 Use of leukotriene antagonists for producing cytoprotective pharmaceutical compositions and process for producing cytoprotective pharmaceutical compositions MERCK & CO. INC. (US) 1985-10-02 EP disclosed
EP-0104885-A1 Leukotriene antagonists, their production, and compositions containing them MERCK FROSST CANADA INC. (CA) 1984-04-04 EP disclosed